Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Natascha K. Schuhmann"'
Autor:
Hildegard Büning, Jessica Sallach, Daniele Avitabile, Gunter Rappl, Maurizio C. Capogrossi, Natascha K. Schuhmann, Luca Perabo, Michael Hallek, Maurizio Pesce, Ombretta Pozzoli, Anke Huber
Publikováno v:
Experimental Hematology. 38:707-717
Objective Bone marrow−derived CD34 + cells are currently used in clinical trials in patients with ischemic heart disease. An option to enhance activity of injected progenitors may be offered by genetic engineering of progenitor cells with angiogeni
Autor:
Anna C. Krajewski, Hildegard Buening, Luca Perabo, Michael J. Noack, Melanie Kunze, Natascha K. Schuhmann, Esther Lowden, Michael Hallek, Anke Huber
Publikováno v:
Journal of Dentistry. 37:502-508
Objectives We explored for the first time the possibility to deliver a reporter gene (Green Fluorescence Protein) to human primary periodontal ligament (PDL) cells and human gingival fibroblasts (HGF) using shuttle vectors derived from adeno-associat
Autor:
Eckart Thein, Michael Schmoeckel, Lars Burdorf, A. Schulz, M. Köhn, H. Büning, M. Hallek, U. Brandl, Natascha K. Schuhmann, B Reichart
Publikováno v:
The Thoracic and Cardiovascular Surgeon. 56
Autor:
Hildegard Büning, Lars Burdorf, J. Postrach, Michael Hallek, Bruno Reichart, Natascha K. Schuhmann, Eckart Thein, Michael Schmoeckel
Publikováno v:
Web of Science
Introduction Adeno-associated virus (AAV) vectors offer the possibility to transfer genes to a wide range of organ and cell types. To determine the efficiency of AAV-mediated gene transfer to cardiac cells, vectors were administered to the heart unde
Autor:
V. Mordstein, M. Hallek, B Reichart, H. Büning, Natascha K. Schuhmann, J. Postrach, Iris Bittmann, Michael Schmoeckel, Lars Burdorf
Publikováno v:
The Thoracic and Cardiovascular Surgeon. 54
Autor:
Sandra Lutz, Lisa Wingenfeld, Joseph E. Rabinowitz, Natascha K. Schuhmann, Susan B. S. King, Ulrich Hacker, Franz M. Gerner, Douglas M. McCarty, Richard Jude Samulski, David M. Kofler, Tobias Herold, Luca Perabo, Hildegard Büning, Michael Hallek
Publikováno v:
The journal of gene medicine. 7(11)
Background Gene therapy is an attractive new approach for the treatment of cancer. Therefore, the development of efficient vector systems is of crucial importance in this field. Different adeno-associated virus (AAV) serotypes have been characterized